Mainz Biomed has the exclusive rights to develop a test for early pancreatic cancer detection using Liquid Biosciences' biomarkers.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Scientists have developed a new chemical method that could make it easier, safer and more environmentally friendly to create ...

Kokoris came up with the idea of solving some of the noise issue of nanopore sequencing by converting DNA into larger ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Welcome to the Department of Biosciences. The department delivers innovative ... The Rosalind Franklin Building is home to Chemistry at NTU and armed with the cutting-edge facilities such as our Super ...

Pacific Biosciences' Q4'24 results were another ... hurt in part by customers working down inventories ahead of a new chemistry launch. Gross margin rose about 12 points from the prior year ...

PACB stock opened at $1.56 on Tuesday. Pacific Biosciences of California has a 12-month low of $1.16 and a 12-month high of $6.09. The company has a quick ratio of 8.64, a current ratio of 9.74 ...

In the last three months, 4 analysts have published ratings on Pacific Biosciences (NASDAQ:PACB), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find ...